While reporting financial results for the second quarter on Friday, biopharmaceutical company AbbVie Inc. (ABBV) confirmed its adjusted earnings guidance for the full-year 2022.
from RTT - Earnings https://ift.tt/kw3Zj4X
via IFTTT
Read More »
from RTT - Earnings https://ift.tt/kw3Zj4X
via IFTTT